BioLife exec has 627 shares withheld for taxes
An EVP and chief scientific officer of BLFS had shares withheld to cover taxes on vested restricted stock units, leaving a substantial direct common stock holding.
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Rhea-AI Filing Summary
BIOLIFE SOLUTIONS INC (BLFS) reported that executive vice president and chief scientific officer Mathew Aby J. had 627 shares of common stock withheld on September 8, 2026 to satisfy tax withholding obligations arising from the release of restricted stock units. The shares were valued at $35.38 per share, and he now directly holds 387,833 shares of common stock. This was a tax-withholding disposition rather than an open-market sale, and no Rule 10b5-1 trading plan is reported.
Insider Trade Summary
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Tax Withholding | Common Stock F1 | 627 | $35.38 | $22K |
Footnotes (1)
- F1. Represents the number of shares withheld by the Issuer to satisfy tax withholding obligations of the reporting person that arose upon the release of restricted stock units.
Key Figures
Key Terms
restricted stock units financial
tax withholding obligations financial
withheld by the Issuer financial
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.
What transaction did BLFS executive Mathew Aby J. report on this Form 4?
Was the BLFS Form 4 transaction executed under a Rule 10b5-1 trading plan?
AI-generated analysis. How Rhea-AI works. Not financial advice.